PERSYVE: design and validation of a questionnaire about adverse effects of antihypertensive drugs
Objective: The aim of this study was to design and validate a questionnaire to measure perceived symptoms associated with antihypertensive drugs (PERSYVE). Methods: The PERSYVE development and validation included four stages: 1) item development (bibliographic review and questionnaire elaboration); 2) face and content validation; 3) field testing (pre-test); and 4) test-retest validation, assessment of internal consistency (Cronbach´s alpha) and reproducibility over time (intraclass correlation coefficient and Cohen´s kappa coefficient). Results: PERSYVE is divided into six sections according to results obtained from the literature review: (1) drug adherence, (2) perceived symptoms and how they affect quality of life (five-point Likert scale), (3) communication with health professionals, (4) perception of symptoms as adverse reactions, (5) influence on therapy compliance, and (6) adoption of non-pharmacological methods for blood pressure control. Content and face validation of the questionnaire led to some vocabulary changes and the introduction of section 2.1. Field-testing (n=26) revealed high comprehensibility of the questions. The Cronbach's alpha, calculated for section 2 (five-point Likert scale) was 0.850. PERSYVE was reproducible (n=167): kappa values presented fair to substantial reproducibility and, in section 2, ICC values resulted in good to excellent reproducibility. Conclusion: Results showed that PERSYVE is a well-structured, objective, patient-friendly, valid and reliable questionnaire. PERSYVE can be a very useful instrument in hypertensive patients´ monitoring and in the screening of adverse effects.
Main Authors: | , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Centro de Investigaciones y Publicaciones Farmacéuticas
2014
|
Online Access: | http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2014000200005 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1885-642X2014000200005 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1885-642X20140002000052017-01-23PERSYVE: design and validation of a questionnaire about adverse effects of antihypertensive drugsDuarte-Silva,DanielaFigueiras,AdolfoHerdeiro,Maria T.Teixeira Rodrigues,AntónioSilva Branco,FábioPolónia,JorgeFigueiredo,Isabel V. Antihypertensive Agents Drug-Related Side Effects and Adverse Reactions Medication Adherence Questionnaires Validation Studies as Topic Portugal Objective: The aim of this study was to design and validate a questionnaire to measure perceived symptoms associated with antihypertensive drugs (PERSYVE). Methods: The PERSYVE development and validation included four stages: 1) item development (bibliographic review and questionnaire elaboration); 2) face and content validation; 3) field testing (pre-test); and 4) test-retest validation, assessment of internal consistency (Cronbach´s alpha) and reproducibility over time (intraclass correlation coefficient and Cohen´s kappa coefficient). Results: PERSYVE is divided into six sections according to results obtained from the literature review: (1) drug adherence, (2) perceived symptoms and how they affect quality of life (five-point Likert scale), (3) communication with health professionals, (4) perception of symptoms as adverse reactions, (5) influence on therapy compliance, and (6) adoption of non-pharmacological methods for blood pressure control. Content and face validation of the questionnaire led to some vocabulary changes and the introduction of section 2.1. Field-testing (n=26) revealed high comprehensibility of the questions. The Cronbach's alpha, calculated for section 2 (five-point Likert scale) was 0.850. PERSYVE was reproducible (n=167): kappa values presented fair to substantial reproducibility and, in section 2, ICC values resulted in good to excellent reproducibility. Conclusion: Results showed that PERSYVE is a well-structured, objective, patient-friendly, valid and reliable questionnaire. PERSYVE can be a very useful instrument in hypertensive patients´ monitoring and in the screening of adverse effects.Centro de Investigaciones y Publicaciones FarmacéuticasPharmacy Practice (Granada) v.12 n.2 20142014-06-01journal articletext/htmlhttp://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2014000200005en |
institution |
SCIELO |
collection |
OJS |
country |
España |
countrycode |
ES |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-es |
tag |
revista |
region |
Europa del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Duarte-Silva,Daniela Figueiras,Adolfo Herdeiro,Maria T. Teixeira Rodrigues,António Silva Branco,Fábio Polónia,Jorge Figueiredo,Isabel V. |
spellingShingle |
Duarte-Silva,Daniela Figueiras,Adolfo Herdeiro,Maria T. Teixeira Rodrigues,António Silva Branco,Fábio Polónia,Jorge Figueiredo,Isabel V. PERSYVE: design and validation of a questionnaire about adverse effects of antihypertensive drugs |
author_facet |
Duarte-Silva,Daniela Figueiras,Adolfo Herdeiro,Maria T. Teixeira Rodrigues,António Silva Branco,Fábio Polónia,Jorge Figueiredo,Isabel V. |
author_sort |
Duarte-Silva,Daniela |
title |
PERSYVE: design and validation of a questionnaire about adverse effects of antihypertensive drugs |
title_short |
PERSYVE: design and validation of a questionnaire about adverse effects of antihypertensive drugs |
title_full |
PERSYVE: design and validation of a questionnaire about adverse effects of antihypertensive drugs |
title_fullStr |
PERSYVE: design and validation of a questionnaire about adverse effects of antihypertensive drugs |
title_full_unstemmed |
PERSYVE: design and validation of a questionnaire about adverse effects of antihypertensive drugs |
title_sort |
persyve: design and validation of a questionnaire about adverse effects of antihypertensive drugs |
description |
Objective: The aim of this study was to design and validate a questionnaire to measure perceived symptoms associated with antihypertensive drugs (PERSYVE). Methods: The PERSYVE development and validation included four stages: 1) item development (bibliographic review and questionnaire elaboration); 2) face and content validation; 3) field testing (pre-test); and 4) test-retest validation, assessment of internal consistency (Cronbach´s alpha) and reproducibility over time (intraclass correlation coefficient and Cohen´s kappa coefficient). Results: PERSYVE is divided into six sections according to results obtained from the literature review: (1) drug adherence, (2) perceived symptoms and how they affect quality of life (five-point Likert scale), (3) communication with health professionals, (4) perception of symptoms as adverse reactions, (5) influence on therapy compliance, and (6) adoption of non-pharmacological methods for blood pressure control. Content and face validation of the questionnaire led to some vocabulary changes and the introduction of section 2.1. Field-testing (n=26) revealed high comprehensibility of the questions. The Cronbach's alpha, calculated for section 2 (five-point Likert scale) was 0.850. PERSYVE was reproducible (n=167): kappa values presented fair to substantial reproducibility and, in section 2, ICC values resulted in good to excellent reproducibility. Conclusion: Results showed that PERSYVE is a well-structured, objective, patient-friendly, valid and reliable questionnaire. PERSYVE can be a very useful instrument in hypertensive patients´ monitoring and in the screening of adverse effects. |
publisher |
Centro de Investigaciones y Publicaciones Farmacéuticas |
publishDate |
2014 |
url |
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2014000200005 |
work_keys_str_mv |
AT duartesilvadaniela persyvedesignandvalidationofaquestionnaireaboutadverseeffectsofantihypertensivedrugs AT figueirasadolfo persyvedesignandvalidationofaquestionnaireaboutadverseeffectsofantihypertensivedrugs AT herdeiromariat persyvedesignandvalidationofaquestionnaireaboutadverseeffectsofantihypertensivedrugs AT teixeirarodriguesantonio persyvedesignandvalidationofaquestionnaireaboutadverseeffectsofantihypertensivedrugs AT silvabrancofabio persyvedesignandvalidationofaquestionnaireaboutadverseeffectsofantihypertensivedrugs AT poloniajorge persyvedesignandvalidationofaquestionnaireaboutadverseeffectsofantihypertensivedrugs AT figueiredoisabelv persyvedesignandvalidationofaquestionnaireaboutadverseeffectsofantihypertensivedrugs |
_version_ |
1755941137104764928 |